Healthcare Nanotechnology Market 2027 By Application, Disease and Geography | The Insight Partners

Healthcare Nanotechnology (Nanomedicine) Market to 2027 - Global Analysis and Forecasts By Application (Drug Delivery, Biomaterials, Active Implants, Diagnostic Imaging, Tissue Regeneration, Other Applications); Disease (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases, Other Diseases) and Geography

Report Code: TIPRE00007260 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Nanotechnology is among the most developing technologies in the present scenario. Nanotechnology is a term used when technical improvements occur at 0.1 to 100 nm scale. Nanomedicine is a field of nanotechnology that includes medicine development at the molecular level for prevention, diagnosis, treatment of diseases, and even redevelopment of tissues and organs. Hence, it aids in preserving and advances human health. Nanomedicine provides a remarkable solution for numerous life-threatening conditions such as Parkinson, Alzheimer's, cancer, diabetes, blood-related diseases, lungs, orthopedic problems, neurological, and cardiovascular system.

MARKET DYNAMICS

Healthcare nanotechnology (nanomedicine) market is anticipated to grow in the forecast period owing to driving factors such as better regulatory framework, rising technological and research funding, and constant increase in the occurrence of chronic diseases like obesity, cancer, kidney disorder, diabetes, and orthopedic conditions. Moreover, increasing government support and awareness of nanomedicine applications are also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Healthcare nanotechnology (nanomedicine) Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of healthcare nanotechnology (nanomedicine) market with detailed market segmentation by application, disease, and geography. The global healthcare nanotechnology (nanomedicine) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading healthcare nanotechnology (nanomedicine) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global healthcare nanotechnology (nanomedicine) market is segmented on the application and disease. Based on application, the market is segmented as drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications. Based on disease, the market is segmented as cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global healthcare nanotechnology (nanomedicine) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The healthcare nanotechnology (nanomedicine) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting healthcare nanotechnology (nanomedicine) market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the healthcare nanotechnology (nanomedicine) market in these regions.

MARKET PLAYERS


The report covers key developments in the healthcare nanotechnology (nanomedicine) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from healthcare nanotechnology (nanomedicine) market are anticipated to lucrative growth opportunities in the future with the rising demand for healthcare nanotechnology (nanomedicine) in the global market. Below mentioned is the list of few companies engaged in the Healthcare nanotechnology (nanomedicine) market.

The report also includes the profiles of key healthcare nanotechnology (nanomedicine) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  Sanofi
  •  Abbott
  •  Pfizer, Inc.
  •  CombiMatrix Corporation
  •  GE Healthcare
  •  Celgene Corporation
  •  Johnson & Johnson Services, Inc.
  •  Luminex Corporation
  •  Merck & Company, Inc.
  •  Nanosphere, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Healthcare Nanotechnology (Nanomedicine) Market - By Application
1.3.2 Healthcare Nanotechnology (Nanomedicine) Market - By Disease
1.3.3 Healthcare Nanotechnology (Nanomedicine) Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET - GLOBAL MARKET ANALYSIS
6.1. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) - GLOBAL MARKET OVERVIEW
6.2. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. DRUG DELIVERY
7.3.1. Overview
7.3.2. Drug Delivery Market Forecast and Analysis
7.4. BIOMATERIALS
7.4.1. Overview
7.4.2. Biomaterials Market Forecast and Analysis
7.5. ACTIVE IMPLANTS
7.5.1. Overview
7.5.2. Active Implants Market Forecast and Analysis
7.6. DIAGNOSTIC IMAGING
7.6.1. Overview
7.6.2. Diagnostic Imaging Market Forecast and Analysis
7.7. TISSUE REGENERATION
7.7.1. Overview
7.7.2. Tissue Regeneration Market Forecast and Analysis
7.8. OTHER APPLICATIONS
7.8.1. Overview
7.8.2. Other Applications Market Forecast and Analysis

8. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE

8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASES
8.3.1. Overview
8.3.2. Cardiovascular Diseases Market Forecast and Analysis
8.4. ONCOLOGICAL DISEASES
8.4.1. Overview
8.4.2. Oncological Diseases Market Forecast and Analysis
8.5. NEUROLOGICAL DISEASES
8.5.1. Overview
8.5.2. Neurological Diseases Market Forecast and Analysis
8.6. ORTHOPEDIC DISEASES
8.6.1. Overview
8.6.2. Orthopedic Diseases Market Forecast and Analysis
8.7. INFECTIOUS DISEASES
8.7.1. Overview
8.7.2. Infectious Diseases Market Forecast and Analysis
8.8. OTHER DISEASES
8.8.1. Overview
8.8.2. Other Diseases Market Forecast and Analysis

9. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Healthcare Nanotechnology (Nanomedicine) Market Overview
9.1.2 North America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis
9.1.3 North America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Application
9.1.4 North America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Disease
9.1.5 North America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Countries
9.1.5.1 United States Healthcare Nanotechnology (Nanomedicine) Market
9.1.5.1.1 United States Healthcare Nanotechnology (Nanomedicine) Market by Application
9.1.5.1.2 United States Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.1.5.2 Canada Healthcare Nanotechnology (Nanomedicine) Market
9.1.5.2.1 Canada Healthcare Nanotechnology (Nanomedicine) Market by Application
9.1.5.2.2 Canada Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.1.5.3 Mexico Healthcare Nanotechnology (Nanomedicine) Market
9.1.5.3.1 Mexico Healthcare Nanotechnology (Nanomedicine) Market by Application
9.1.5.3.2 Mexico Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.2. EUROPE
9.2.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Overview
9.2.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis
9.2.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Application
9.2.4 Europe Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Disease
9.2.5 Europe Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Healthcare Nanotechnology (Nanomedicine) Market
9.2.5.1.1 Germany Healthcare Nanotechnology (Nanomedicine) Market by Application
9.2.5.1.2 Germany Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.2.5.2 France Healthcare Nanotechnology (Nanomedicine) Market
9.2.5.2.1 France Healthcare Nanotechnology (Nanomedicine) Market by Application
9.2.5.2.2 France Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.2.5.3 Italy Healthcare Nanotechnology (Nanomedicine) Market
9.2.5.3.1 Italy Healthcare Nanotechnology (Nanomedicine) Market by Application
9.2.5.3.2 Italy Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.2.5.4 Spain Healthcare Nanotechnology (Nanomedicine) Market
9.2.5.4.1 Spain Healthcare Nanotechnology (Nanomedicine) Market by Application
9.2.5.4.2 Spain Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.2.5.5 United Kingdom Healthcare Nanotechnology (Nanomedicine) Market
9.2.5.5.1 United Kingdom Healthcare Nanotechnology (Nanomedicine) Market by Application
9.2.5.5.2 United Kingdom Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Overview
9.3.2 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis
9.3.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Disease
9.3.5 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Healthcare Nanotechnology (Nanomedicine) Market
9.3.5.1.1 Australia Healthcare Nanotechnology (Nanomedicine) Market by Application
9.3.5.1.2 Australia Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.3.5.2 China Healthcare Nanotechnology (Nanomedicine) Market
9.3.5.2.1 China Healthcare Nanotechnology (Nanomedicine) Market by Application
9.3.5.2.2 China Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.3.5.3 India Healthcare Nanotechnology (Nanomedicine) Market
9.3.5.3.1 India Healthcare Nanotechnology (Nanomedicine) Market by Application
9.3.5.3.2 India Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.3.5.4 Japan Healthcare Nanotechnology (Nanomedicine) Market
9.3.5.4.1 Japan Healthcare Nanotechnology (Nanomedicine) Market by Application
9.3.5.4.2 Japan Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.3.5.5 South Korea Healthcare Nanotechnology (Nanomedicine) Market
9.3.5.5.1 South Korea Healthcare Nanotechnology (Nanomedicine) Market by Application
9.3.5.5.2 South Korea Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Market Overview
9.4.2 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis
9.4.3 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Disease
9.4.5 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Healthcare Nanotechnology (Nanomedicine) Market
9.4.5.1.1 South Africa Healthcare Nanotechnology (Nanomedicine) Market by Application
9.4.5.1.2 South Africa Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.4.5.2 Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Market
9.4.5.2.1 Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Market by Application
9.4.5.2.2 Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.4.5.3 U.A.E Healthcare Nanotechnology (Nanomedicine) Market
9.4.5.3.1 U.A.E Healthcare Nanotechnology (Nanomedicine) Market by Application
9.4.5.3.2 U.A.E Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Healthcare Nanotechnology (Nanomedicine) Market Overview
9.5.2 South and Central America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis
9.5.3 South and Central America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Application
9.5.4 South and Central America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Disease
9.5.5 South and Central America Healthcare Nanotechnology (Nanomedicine) Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Healthcare Nanotechnology (Nanomedicine) Market
9.5.5.1.1 Brazil Healthcare Nanotechnology (Nanomedicine) Market by Application
9.5.5.1.2 Brazil Healthcare Nanotechnology (Nanomedicine) Market by Disease
9.5.5.2 Argentina Healthcare Nanotechnology (Nanomedicine) Market
9.5.5.2.1 Argentina Healthcare Nanotechnology (Nanomedicine) Market by Application
9.5.5.2.2 Argentina Healthcare Nanotechnology (Nanomedicine) Market by Disease

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. HEALTHCARE NANOTECHNOLOGY (NANOMEDICINE) MARKET, KEY COMPANY PROFILES

11.1. SANOFI
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBOTT
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. COMBIMATRIX CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GE HEALTHCARE
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CELGENE CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JOHNSON & JOHNSON SERVICES, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. LUMINEX CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK AND COMPANY, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NANOSPHERE, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi
2. Abbott
3. Pfizer, Inc.
4. CombiMatrix Corporation
5. GE Healthcare
6. Celgene Corporation
7. Johnson & Johnson Services, Inc.
8. Luminex Corporation
9. Merck & Company, Inc.
10. Nanosphere, Inc.